We hereby provide the summary and presentations as given during the meeting organized by the Dutch Society of Toxicology Section Pharmaceutical Toxicology and Section Risk Assessment on the 5th of April 2022.
One substance – Multiple assessments
Titanium Dioxide considered from a food and pharma perspective
|Introduction: one substance – one assessment|
|Titanium Dioxide: regulatory and risk assessment aspects from a food perspective|
|Titanium Dioxide: regulatory and risk assessment aspects, and its implications from a pharma perspective|
|Titanium Dioxide: Communication to patients|